Bloomberg’s Caroline Hyde and Ed Ludlow discuss the possible impact of trade talks between the US and China. Plus, Lyft CEO David Risher talks about the markets where the company is investing. And, DraftKings CEO, Jason Robins, explains the impact of a surprising March Madness.

Bloomberg&rsquo;s Caroline Hyde and Ed Ludlow discuss the possible impact of trade talks between the US and China. Plus, Lyft CEO David Risher talks about the markets where the company is investing. And, DraftKings CEO, Jason Robins, explains the impact of a surprising March Madness.

The only daily news program focused exclusively on technology, innovation and the future of business.

The only daily news program focused exclusively on technology, innovation and the future of business.

Bloomberg Technology is the only daily news program focused exclusively on technology, innovation and the future of business.

Bloomberg Tech

Apple Developing Chips for AI Servers, Lyft CEO Talks Growth Plans

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/a7c04416-2dde-47ab-b695-b2d801271a86/transcript

Bloomberg’s Caroline Hyde and Ed Ludlow discuss President Trump’s decision to allow Nvidia to ship its H200 AI chip to China, in exchange for a 25% surcharge. Plus, the battle for Warner Bros. heats up, as antitrust concerns swirl around both Netflix’s and Paramount Skydance’s offers. And Microsoft is committing $17.5 billion over four years to help build India's cloud and AI infrastructure.

Bloomberg&rsquo;s Caroline Hyde and Ed Ludlow discuss President Trump&rsquo;s decision to allow Nvidia to ship its H200 AI chip to China, in exchange for a 25% surcharge. Plus, the battle for Warner Bros. heats up, as antitrust concerns swirl around both Netflix&rsquo;s and Paramount Skydance&rsquo;s offers. And Microsoft is committing $17.5 billion over four years to help build India's cloud and AI infrastructure.

Nvidia Wins US Approval to Sell H200 Chips to China

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/5b7fcd54-2594-4ea0-a8bc-b3ae012f6db9/transcript

Bloomberg’s Caroline Hyde and Ed Ludlow discuss Paramount Skydance’s $30 per share bid for Warner Bros. Discovery that comes just days after the company agreed to a deal with Netflix. Plus, President Trump wants to limit state-level AI regulation with an executive order aiming for "one rule" on artificial intelligence, and IBM is buying data-streaming platform Confluent for about $9.3 billion in one of its largest takeovers yet.

Bloomberg&rsquo;s Caroline Hyde and Ed Ludlow discuss Paramount Skydance&rsquo;s $30 per share bid for Warner Bros. Discovery that comes just days after the company agreed to a deal with Netflix. Plus, President Trump wants to limit state-level AI regulation with an executive order aiming for "one rule" on artificial intelligence, and IBM is buying data-streaming platform Confluent for about $9.3 billion in one of its largest takeovers yet.

Paramount Makes Hostile Bid for Warner Bros. Discovery

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/6154d9f1-6efd-41bd-814d-b3ad0188b489/transcript

Rachel Benton is a loving mother to an adorable 2-year-old boy named Stetson. Stetson doesn’t know it, but he may have already saved his mom’s life. A routine medical checkup, that Rachel only had because she was pregnant, showed protein in her urine. That discovery led to a biopsy and ultimately a diagnosis of IgA nephropathy – a serious kidney disease. With patients like Rachel in mind, the research team at Vertex Pharmaceuticals is working on new approaches to address IgA nephropathy. 

Produced by Bloomberg Media Studios and Vertex Pharmaceuticals.

Rachel Benton is a loving mother to an adorable 2-year-old boy named Stetson. Stetson doesn&rsquo;t know it, but he may have already saved his mom&rsquo;s life. A routine medical checkup, that Rachel only had because she was pregnant, showed protein in her urine. That discovery led to a biopsy and ultimately a diagnosis of IgA nephropathy &ndash; a serious kidney disease. With patients like Rachel in mind, the research team at Vertex Pharmaceuticals is working on new approaches to address IgA nephropathy.&nbsp;
Produced by Bloomberg Media Studios and Vertex Pharmaceuticals.

Targeting IgA Nephropathy (Sponsored Content)

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/964b36d0-27ce-4a51-b1c7-b3aa011915a0/transcript

Apple Developing Chips for AI Servers, Lyft CEO Talks Growth Plans

In 1 playlist(s)

Bloomberg Tech

Social links

Follow podcast

Recent clips